Protein Biomarkers Market
- 2026 年市場規模
- USD 9,925.9 Mn
- 2033 年預估規模
- USD 17,686.6 Mn
- 年複合成長率 CAGR
- 8.6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Protein Biomarkers Market, By Biomarker Type (Oncology Protein Biomarkers, Cardiac Protein Biomarkers, Inflammatory and Sepsis Protein Biomarkers, Neurology Protein Biomarkers, Autoimmune Protein Biomarkers, Metabolic Protein Biomarkers, and Others), By Application (Biomarker Discovery and Validation, Drug Discovery and Clinical Trial Support, Assay Development, Antibody Development, and Others), By End User (IVD and Diagnostic Assay Manufacturers, Pharmaceutical and Biotechnology Companies, CROs and Biomarker Testing Service Providers, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global protein biomarkers market is estimated to be valued at USD 9,925.9 Mn in 2026 and is expected to reach USD 17,686.6 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2026 to 2033. Protein biomarkers are molecules in bodily fluid or tissue that help researchers, scientists, or clinicians measure the functional state of a tissue, monitor disease progression, or indicate normal/abnormal function or response to treatment. Protein biomarkers offer a valuable strategy for cancer, cardiovascular and neurological disorder detection and diagnoses, patient stratification, infectious disease, and therapy.
The global protein biomarkers market is growing significantly as a result of recent developments and adoption of technologies such as proteomics, mass spectrometry, and next generation sequencing and the increase in the application of AI driven data analytics. The market consists of biomarker discovery and validation platforms, diagnostic assays, reagents and bioinformatics solutions, and it serves pharmaceutical and biotechnology companies, clinical laboratories, contract research organizations, and academic research institutions, while also supporting the growing use of precision medicine.
Market Dynamics
The global protein biomarkers market is driven by increasing occurrence of cancer, cardiovascular disorders, diabetes and neurodegenerative conditions leading to a demand for quick and early detection and diagnosis. The development and launch of protein biomarker tests is gaining traction with enhanced precision medicine practices and the emergence of novel technologies including multiplex immunoassays, mass spectrometry, and the progress of proteomic technologies. Growing expenditure in biomarker discovery research are further accelerating the development and commercialization of protein biomarker-based diagnostics.
However, a number of constraints are present in the market, such as high costs associated with biomarker discovery and validation, stringent regulatory requirements, and issues related to assay standardization and reproducibility. Nevertheless, expanding applications of liquid biopsy, integration of AI and machine learning in biomarker discovery, and increasing adoption of point-of-care diagnostics will offer new opportunities for growth in protein biomarkers market.
Key Features of the Study
• This report provides in-depth analysis of the global protein biomarkers market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global protein biomarkers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies, Inc., Merck KGaA, QIAGEN N.V., Bio-Rad Laboratories, Inc., Revvity, Inc., Bio-Techne Corporation, and Quanterix Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global protein biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global protein biomarkers market
Market Segmentation
• Biomarker Type Insights (Revenue, USD Mn, 2021 - 2033)
o Oncology Protein Biomarkers
o Cardiac Protein Biomarkers
o Inflammatory and Sepsis Protein Biomarkers
o Neurology Protein Biomarkers
o Autoimmune Protein Biomarkers
o Metabolic Protein Biomarkers
o Others
• Application Insights (Revenue, USD Mn, 2021 - 2033)
o Biomarker Discovery and Validation
o Drug Discovery and Clinical Trial Support
o Assay Development
o Antibody Development
o Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o IVD and Diagnostic Assay Manufacturers
o Pharmaceutical and Biotechnology Companies
o CROs and Biomarker Testing Service Providers
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Hoffmann-La Roche Ltd.
o Thermo Fisher Scientific Inc.
o Abbott Laboratories
o Agilent Technologies, Inc.
o Merck KGaA
o QIAGEN N.V.
o Bio-Rad Laboratories, Inc.
o Revvity, Inc.
o Bio-Techne Corporation
o Quanterix Corporation
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Protein Biomarkers Market, By Biomarker Type
Global Protein Biomarkers Market, By Application
Global Protein Biomarkers Market, By End User
Global Protein Biomarkers Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Industry Trends
4. Global Protein Biomarkers Market, By Biomarker Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Oncology Protein Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Cardiac Protein Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Inflammatory and Sepsis Protein Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Neurology Protein Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Autoimmune Protein Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Metabolic Protein Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Protein Biomarkers Market, By Application, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Biomarker Discovery and Validation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Drug Discovery and Clinical Trial Support
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Assay Development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Antibody Development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Protein Biomarkers Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o IVD and Diagnostic Assay Manufacturers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Pharmaceutical and Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o CROs and Biomarker Testing Service Providers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Protein Biomarkers Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Biomarker Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
8. Competitive Landscape
o Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Thermo Fisher Scientific Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Abbott Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Agilent Technologies, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Merck KGaA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o QIAGEN N.V.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bio-Rad Laboratories, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Revvity, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bio-Techne Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Quanterix Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
10. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Protein Biomarkers Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們